These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6977481)

  • 41. Obtention of Sm antigen from L5178 murine lymphoma malignant cells.
    Lamas-Robles C; Mejía-Arreguín S; Gómez-Estrada H; González-Mendoza A
    Arch Invest Med (Mex); 1984; 15(3):259-65. PubMed ID: 6443059
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.
    Levy JG; Smith AG; Whitney RB; McMaster R; Kilburn DG
    Immunology; 1976 Apr; 30(4):565-73. PubMed ID: 131782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like and cytotoxic T lymphocyte activity.
    Zangemeister-Wittke U; Kyewski B; Schirrmacher V
    J Immunol; 1989 Jul; 143(1):379-85. PubMed ID: 2499633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mechanism of intercellular aggregation. I. The kinetics of the Fc gamma receptor-mediated aggregation of P388D1 cells with antibody-coated lymphocytes at 4 degrees C.
    Segal DM; Stephany DA
    J Immunol; 1984 Apr; 132(4):1924-30. PubMed ID: 6230397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo generation and selection of variants with altered sensitivity to natural resistance (NR): a model of tumor progression.
    Chow DA; Ray M; Greenberg AH
    Int J Cancer; 1983 Jan; 31(1):99-105. PubMed ID: 6832850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fc receptors of mouse cell lines. II. IgG binding specificity and identification of the Fc receptor on a lymphoid leukemia.
    Lane BC; Bricker MD; Cooper SM
    J Immunol; 1982 Apr; 128(4):1825-31. PubMed ID: 6977571
    [No Abstract]   [Full Text] [Related]  

  • 49. Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen.
    Bachmann MF; Kündig TM; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1994 Oct; 24(10):2567-70. PubMed ID: 7925584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance and cure of the L5178Y murine tumor-dormant state by interleukin 2: in vivo and in vitro effects.
    Liu CM; Suzuki Y; Chen LP; Okayasu T; Calkins CE; Wheelock EF
    Cancer Res; 1990 Mar; 50(5):1361-7. PubMed ID: 2302701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interaction of monomeric and complexed mouse monoclonal IgG with rat basophilic leukemia cells: a subset of IgG molecules can bind to RBL cell Fc receptors for IgG.
    Hall TJ; Rittenberg MB
    J Immunol; 1986 Oct; 137(7):2331-8. PubMed ID: 2944953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL; Stillman WS
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.
    Van den Berg CW; Hazenberg MA; Hofhuis FM; Van Rooyen SM; Van Dijk H
    Immunology; 1991 Jul; 73(3):264-70. PubMed ID: 1879875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on specific humoral immunity in leukemia.
    Bergolz VM
    Neoplasma; 1976; 23(5):457-62. PubMed ID: 790209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Murine lymphoma cells possess blood group Tn-, T-, N-, M- and S-active substances.
    Springer GF; Desai PR; Tegtmeyer H; Schirmacher V; Cheingsong-Popov R
    Naturwissenschaften; 1983 Feb; 70(2):98-9. PubMed ID: 6843686
    [No Abstract]   [Full Text] [Related]  

  • 57. Uptake and decomposition of chlorambucil by L5178Y lymphoblasts in vitro.
    Begleiter A; Goldenberg GJ
    Biochem Pharmacol; 1983 Feb; 32(3):535-9. PubMed ID: 6847702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Univalent antibodies kill tumour cells in vitro and in vivo.
    Glennie MJ; Stevenson GT
    Nature; 1982 Feb; 295(5851):712-4. PubMed ID: 7057931
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.
    Gregoriadis G
    Drugs; 1982 Oct; 24(4):261-6. PubMed ID: 7140578
    [No Abstract]   [Full Text] [Related]  

  • 60. Tumour cell-antibody interactions. I. In vivo experiments.
    Froese G; Berczi I; Israels LG
    Immunology; 1982 Feb; 45(2):303-12. PubMed ID: 7061100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.